2011, Archäologie, Inschriften und Denkmäler Altägyptens, ISBN 3867575312, Volume Band 1, 80
Book
The New England Journal of Medicine, ISSN 0028-4793, 06/2015, Volume 372, Issue 25, pp. 2387 - 2397
In this trial, patients with an acute coronary syndrome within the previous 10 days were randomly assigned to simvastatin plus either ezetimibe or placebo. At...
CHOLESTEROL ABSORPTION | CARDIAC OUTCOMES | MEDICINE, GENERAL & INTERNAL | MYOCARDIAL-INFARCTION | EFFICACY | CARDIOVASCULAR OUTCOMES | CLINICAL-TRIALS | SIMVASTATIN | PRIMARY PREVENTION | IMPROVE-IT | ATORVASTATIN | Simvastatin - therapeutic use | Double-Blind Method | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Azetidines - adverse effects | Ezetimibe | Kaplan-Meier Estimate | Male | Anticholesteremic Agents - adverse effects | Acute Coronary Syndrome - drug therapy | Anticholesteremic Agents - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Azetidines - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Triglycerides - blood | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Cholesterol, LDL - blood | Female | Aged | Drug Therapy, Combination | Usage | Simvastatin | Analysis | Practice guidelines (Medicine) | Dosage and administration | Drug therapy, Combination | Acute coronary syndrome | Drug therapy | Myocardial infarction | Cerebral infarction | Lipoproteins (low density) | Stroke | Angina | Cholesterol | Intestine | Gallbladder | Acute coronary syndromes | Cardiovascular diseases | Statins | Pharmaceuticals | Cancer | Life Sciences | Human health and pathology | Cardiology and cardiovascular system
CHOLESTEROL ABSORPTION | CARDIAC OUTCOMES | MEDICINE, GENERAL & INTERNAL | MYOCARDIAL-INFARCTION | EFFICACY | CARDIOVASCULAR OUTCOMES | CLINICAL-TRIALS | SIMVASTATIN | PRIMARY PREVENTION | IMPROVE-IT | ATORVASTATIN | Simvastatin - therapeutic use | Double-Blind Method | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Azetidines - adverse effects | Ezetimibe | Kaplan-Meier Estimate | Male | Anticholesteremic Agents - adverse effects | Acute Coronary Syndrome - drug therapy | Anticholesteremic Agents - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Azetidines - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Triglycerides - blood | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Cholesterol, LDL - blood | Female | Aged | Drug Therapy, Combination | Usage | Simvastatin | Analysis | Practice guidelines (Medicine) | Dosage and administration | Drug therapy, Combination | Acute coronary syndrome | Drug therapy | Myocardial infarction | Cerebral infarction | Lipoproteins (low density) | Stroke | Angina | Cholesterol | Intestine | Gallbladder | Acute coronary syndromes | Cardiovascular diseases | Statins | Pharmaceuticals | Cancer | Life Sciences | Human health and pathology | Cardiology and cardiovascular system
Journal Article
2009, Network professional's library, ISBN 9780071614030
Web Resource
2009, ISBN 9780071614030
Web Resource
American Heart Journal, ISSN 0002-8703, 2010, Volume 160, Issue 5, pp. 785 - 794.e10
Background Lowering low-density lipoprotein (LDL) cholesterol with statin therapy has been shown to reduce the incidence of atherosclerotic events in many...
Cardiovascular | UNITED-KINGDOM HEART | METAANALYSIS | REQUIRING PROLONGED OBSERVATION | EFFICACY | CARDIOVASCULAR OUTCOMES | SAFETY | CLINICAL-TRIALS | SIMVASTATIN | EZETIMIBE | STATINS | UMCG Approved | DESIGN | CARDIAC & CARDIOVASCULAR SYSTEMS | Simvastatin - therapeutic use | Follow-Up Studies | Humans | Middle Aged | Ezetimibe | Male | Incidence | Dose-Response Relationship, Drug | Atherosclerosis - etiology | Adult | Cholesterol, LDL - blood | Female | Retrospective Studies | Drug Therapy, Combination | Double-Blind Method | Simvastatin - administration & dosage | Cholesterol, LDL - drug effects | Treatment Outcome | Atherosclerosis - blood | Kidney Failure, Chronic - therapy | Anticholesteremic Agents - therapeutic use | Azetidines - administration & dosage | Azetidines - therapeutic use | Kidney Failure, Chronic - blood | Anticholesteremic Agents - administration & dosage | Kidney Failure, Chronic - complications | Aged | Atherosclerosis - prevention & control | Renal Dialysis | Medicine, Experimental | Medical research | Chronic kidney failure | Analysis | Low density lipoproteins | Cholesterol | Lipids | Heart attacks | Drug therapy | Low density lipoprotein | Clinical Medicine | Urologi och njurmedicin | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap | Urology and Nephrology
Cardiovascular | UNITED-KINGDOM HEART | METAANALYSIS | REQUIRING PROLONGED OBSERVATION | EFFICACY | CARDIOVASCULAR OUTCOMES | SAFETY | CLINICAL-TRIALS | SIMVASTATIN | EZETIMIBE | STATINS | UMCG Approved | DESIGN | CARDIAC & CARDIOVASCULAR SYSTEMS | Simvastatin - therapeutic use | Follow-Up Studies | Humans | Middle Aged | Ezetimibe | Male | Incidence | Dose-Response Relationship, Drug | Atherosclerosis - etiology | Adult | Cholesterol, LDL - blood | Female | Retrospective Studies | Drug Therapy, Combination | Double-Blind Method | Simvastatin - administration & dosage | Cholesterol, LDL - drug effects | Treatment Outcome | Atherosclerosis - blood | Kidney Failure, Chronic - therapy | Anticholesteremic Agents - therapeutic use | Azetidines - administration & dosage | Azetidines - therapeutic use | Kidney Failure, Chronic - blood | Anticholesteremic Agents - administration & dosage | Kidney Failure, Chronic - complications | Aged | Atherosclerosis - prevention & control | Renal Dialysis | Medicine, Experimental | Medical research | Chronic kidney failure | Analysis | Low density lipoproteins | Cholesterol | Lipids | Heart attacks | Drug therapy | Low density lipoprotein | Clinical Medicine | Urologi och njurmedicin | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap | Urology and Nephrology
Journal Article
Law and Business Review of the Americas, ISSN 1571-9537, 07/2013, Volume 19, Issue 3, p. 411
On Jun 13, 2013, the Supreme Court of Canada heard oral argument in Canada (Attorney General) v. Bedford. Final argument in front of the Supreme Court was...
Supreme Court decisions | Prostitution | Law
Supreme Court decisions | Prostitution | Law
Journal Article
Scientific Reports, ISSN 2045-2322, 12/2017, Volume 7, Issue 1, pp. 10371 - 15
Protein-bound uremic toxins (PBUTs) are difficult to remove by conventional hemodialysis; a high degree of protein binding reduces the free fraction of toxins...
INDOXYL SULFATE | KT/V-UREA | CLEARANCE | REMOVAL | MULTIDISCIPLINARY SCIENCES | SOLUTES | P-CRESOL | MEMBRANES | CHRONIC KIDNEY-DISEASE | BINDING | DIALYSATE FLOW | Models, Theoretical | Reproducibility of Results | Toxins, Biological - blood | Dialysis Solutions | Humans | Middle Aged | Uremia - metabolism | Uremia - blood | Toxins, Biological - metabolism | Aged, 80 and over | Protein Binding | Aged | Kinetics | Renal Dialysis | Proteins | Hemodialysis | Indole | Toxins | Sulfate | Acetic acid | Blood flow
INDOXYL SULFATE | KT/V-UREA | CLEARANCE | REMOVAL | MULTIDISCIPLINARY SCIENCES | SOLUTES | P-CRESOL | MEMBRANES | CHRONIC KIDNEY-DISEASE | BINDING | DIALYSATE FLOW | Models, Theoretical | Reproducibility of Results | Toxins, Biological - blood | Dialysis Solutions | Humans | Middle Aged | Uremia - metabolism | Uremia - blood | Toxins, Biological - metabolism | Aged, 80 and over | Protein Binding | Aged | Kinetics | Renal Dialysis | Proteins | Hemodialysis | Indole | Toxins | Sulfate | Acetic acid | Blood flow
Journal Article
Science of the Total Environment, ISSN 0048-9697, 07/2018, Volume 628-629, pp. 1369 - 1394
Through litter decomposition enormous amounts of carbon is emitted to the atmosphere. Numerous large-scale decomposition experiments have been conducted...
Tea bag | TeaComposition initiative | Green tea | Rooibos tea | Carbon turnover | CARBON | TERRESTRIAL ECOSYSTEMS | CLIMATE-CHANGE | PATTERNS | MODEL | RATES | ENVIRONMENTAL SCIENCES | DYNAMICS | IMPACTS | TRAITS | FEEDBACK | Biomes | Analysis | Biodiversity and Ecology | Environmental Sciences | Agricultural Science, Forestry and Fisheries | Soil Science | Lantbruksvetenskap och veterinärmedicin | Markvetenskap | Agricultural and Veterinary sciences | Lantbruksvetenskap, skogsbruk och fiske
Tea bag | TeaComposition initiative | Green tea | Rooibos tea | Carbon turnover | CARBON | TERRESTRIAL ECOSYSTEMS | CLIMATE-CHANGE | PATTERNS | MODEL | RATES | ENVIRONMENTAL SCIENCES | DYNAMICS | IMPACTS | TRAITS | FEEDBACK | Biomes | Analysis | Biodiversity and Ecology | Environmental Sciences | Agricultural Science, Forestry and Fisheries | Soil Science | Lantbruksvetenskap och veterinärmedicin | Markvetenskap | Agricultural and Veterinary sciences | Lantbruksvetenskap, skogsbruk och fiske
Journal Article